https://orcid.org/0000-0001-9099-6267
References
- Baltinas J, Lightman S, Tomkins-Netzer O. Comparing treatment of acute retinal necrosis with either oral valacyclovir or intravenous acyclovir. Am J Ophthalmol. 2018;188(4):173–180. doi:10.1016/j.ajo.2018.02.001.
- Weller S, Blum MR, Doucette M, et al. Pharmacokinetics of the acyclovir pro-drug valacyclovir after escalating single and multiple-dese administration to normal vonlunteers. Clin Pharmacol Ther. 1993;54:595–605.
- Schoenbergern SD, Kim SJ, Thorne JE, et al. Diagnosis and treatment of acute retinal necrosis: a report by American academy of ophthalmology. Opththlamology. 2017;124:382–392. doi:10.1016/j.ophtha.2016.11.007.
- Lee JH, Agarwal A, Mahendradas P, et al. viral posterior uveitis. Surv Ophthalmol. 2017;62(4):404–445. doi:10.1016/j.survophthal.2016.12.008.
- Guex-Crosier Y, Meylan PR. High dosage of oral valacyclovir as an alternative treatment of varicella zoster acute retinal necrosis syndrome. Eye. 2006;20:247. doi:10.1038/sj.eye.6701821.